An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome

NCT00401258 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Irritable Bowel Syndrome

Interventions

DRUG: duloxetine

Sponsor

Mclean Hospital

Collaborators

[object Object]